logo
Schedule a Meeting

Integrated Symposium ECCMID 2021

The Crucial Role of Rapid Diagnostics in the Early Detection of Secondary Bacterial and Fungal Infections Complicating COVID-19

Rapid diagnostics will play a vital role in the future of combatting infectious diseases. The COVID-19 pandemic has highlighted the prevalence of secondary and co-infections in patients diagnosed with COVID-19. Rapid diagnostics can aid in identifying secondary and co-infections in these patients early. Current diagnostic methods are limited by lack of sensitivity and extended time to the identification of causative pathogens. Earlier identification of causative pathogens allows for faster-targeted therapy, thus aiding in improving patient outcomes and combatting antimicrobial resistance.

Speakers

  • Dr. Aparna Ahuja, T2 Biosystems, USA

  • Dr. Thomas Walsh, Weill Cornell Medicine, USA

  • Dr. Tamara Seitz, SMZ Süd, Austria

 

Popular Posts

According to the CDC, of the 154 million prescriptions for antibiotics written in doctors’ offices and emergency departments each year, 30% are unnecessary.12

PUBLICATIONS

Over 200 studies published in peer-reviewed journals have featured T2MR in a breadth of applications.

Read Now!

T2 BIOSYSTEMS OVERVIEW

T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before. T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most expensive conditions in hospitals today.

The T2Dx Instrument, the T2Bacteria and T2Candida Panels have received marketing authorization from the U.S. Food and Drug Administration. All other T2 Biosystems products are considered investigational and for research use only.

T2 Biosystems®, T2MR®, T2Bacteria®, T2Candida®, T2Resistance® and T2Dx® are registered trademarks of T2 Biosystems, Inc. “T2Biosystems” and the T2 Biosystems, Inc. logo design are registered trademarks or trademarks of T2Biosystems, Inc. All software and documentation is subject to T2 Biosystems, Inc. copyrights. All rights reserved. T2Direct Diagnostics™, T2HemoStat™, T2Plex™, T2Cauris™, T2Lyme™ and T2SARS-CoV-2™ are trademarks of T2 Biosystems, Inc.

© 2024 T2 Biosystems, Inc.

SITEMAP

FOLLOW US ON SOCIAL

Linkedin-in Twitter

Please tell us where you are visiting from: United States | Outside the United States